These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15432303)

  • 21. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 22. [AC globulin and SPCA: two plasma factors in the conversion of prothrombin; clinical and biological study and review].
    ALEXANDER B
    Rev Hematol; 1952; 7(2):168-227. PubMed ID: 14958229
    [No Abstract]   [Full Text] [Related]  

  • 23. Some biochemical and electrophoretic studies on purified prothrombin, factor VII (proconvertin) and factor X (Stuart).
    TISHKOFF GH; PECHET L; ALEXANDER B
    Blood; 1960 May; 15():778-90. PubMed ID: 13838500
    [No Abstract]   [Full Text] [Related]  

  • 24. Prothrombin activity and its relation to medical therapy.
    LEPP E
    Can J Med Technol; 1949 Mar; 11(1):1-16. PubMed ID: 18112192
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on the prothrombin complex in mature and and premature infants. I. On prothrombin, factor V and factor VII-complex in mature and premature infants].
    MORII N
    Paediatr Jpn; 1961; 65():260-7. PubMed ID: 13772659
    [No Abstract]   [Full Text] [Related]  

  • 26. Prothrombin, thromboplastin, Ac-globulin and platelet accelerator: quantitative interrelationships.
    McCLAUGHRY RI; SEEGERS WH
    Blood; 1950 Apr; 5(4):303-12. PubMed ID: 15411418
    [No Abstract]   [Full Text] [Related]  

  • 27. [EXPERIMENTAL STUDIES ON THE EFFECT OF CIGARETTE SMOKING ON THE COAGULATION TIME OF NORMAL BLOOD AND CALCIUM-TREATED BLOOD AND ON THE PROTHROMBIN AND THROMBIN TIME OF HUMAN SERUM].
    LISIEWICZ J
    Pol Tyg Lek; 1963 Sep; 18():1471-3. PubMed ID: 14082331
    [No Abstract]   [Full Text] [Related]  

  • 28. The antithrombic activity of carrageenin in human blood.
    HAWKINS WW; LEONARD VG
    Can J Biochem Physiol; 1963 May; 41():1325-7. PubMed ID: 13953223
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of tromexan and dicumarol on clotting time and prothrombin index].
    KRISTENSON A
    Nord Med; 1951 Jul; 46(29):1102-4. PubMed ID: 14863696
    [No Abstract]   [Full Text] [Related]  

  • 30. Congenital familial deficiency of the stable prothrombin conversion factor; restudy of case originally reported as idiopathic hypoprothrombinemia.
    FRICK PG; HAGEN PS
    J Lab Clin Med; 1953 Aug; 42(2):212-23. PubMed ID: 13069867
    [No Abstract]   [Full Text] [Related]  

  • 31. [BLOOD COAGULATION AND VARIOUS HEMOCOAGULATING FACTORS DURING THE MENSTRUAL CYCLE].
    MARES J
    Cesk Gynekol; 1965 May; 30():244-8. PubMed ID: 14346470
    [No Abstract]   [Full Text] [Related]  

  • 32. [THE BEHAVIOR OF DIFFERENT BLOOD COAGULATION FACTORS IN IRRADIATION OF GYNECOLOGICAL CARCINOMA WITH COBALT 60].
    GRAEBER W
    Strahlentherapie; 1964 May; 124():60-8. PubMed ID: 14216959
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of phenylindanedione on plasma prothrombin and factor V levels and a comparison with the effect of dicumarol.
    BJERKELUND CJ
    Scand J Clin Lab Invest; 1950; 2(2):83-91. PubMed ID: 15424627
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of aureomycin upon blood coagulation time, Ac-globulin and prothrombin activity.
    INNERFIELD I; ANGRIST A; BENJAMIN JW; KANEGIS LA
    Am J Physiol; 1951 Sep; 166(3):578-83. PubMed ID: 14885446
    [No Abstract]   [Full Text] [Related]  

  • 35. [CHANGES IN THE ACTIVITY OF INDIVIDUAL FACTORS OF THE PROTHROMBIN COMPLEX IN AGING OF THE PLASMA].
    MARES J; PODLIPNY J
    Z Arztl Fortbild (Jena); 1964 Jun; 58():655-8. PubMed ID: 14241491
    [No Abstract]   [Full Text] [Related]  

  • 36. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man.
    DIDISHEIM P; LOEB J; BLATRIX C; SOULIER JP
    J Lab Clin Med; 1959 Feb; 53(2):322-30. PubMed ID: 13621053
    [No Abstract]   [Full Text] [Related]  

  • 37. Interpretation and reporting of prothrombin activity; including a method of converting prothrombin time to percentage of prothrombin activity.
    BRONSTEIN MR
    J Med Soc N J; 1952 Dec; 49(12):511-4. PubMed ID: 13011602
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of synthetic vitamin K1 on prothrombin, factor VII complex and factor IX in premature infants].
    YOSHIDA K; MORII N; KANMI M; YOSHIDA K
    Paediatr Jpn; 1963 Jun; 67():373-8. PubMed ID: 14002672
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of several diluents on prothrombin activity curves.
    FISHER B
    Br J Exp Pathol; 1949 Aug; 30(4):352-5. PubMed ID: 15393425
    [No Abstract]   [Full Text] [Related]  

  • 40. ROLE OF THROMBIN IN PROTHROMBIN ACTIVATION.
    SEEGERS WH; SCHROEER H; HEENE D
    Thromb Diath Haemorrh; 1964 Dec; 12():484-8. PubMed ID: 14254705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.